Universal Mass Vaccination
Showing 1 - 25 of >10,000
Metastatic NSCLC Trial in France (UCPVax)
Active, not recruiting
- Metastatic Non-small Cell Lung Cancer
-
Besancon, France
- +4 more
Sep 22, 2022
Evaluation of Universal Rotavirus Vaccination Program
Completed
- Gastrointestinal Diseases
-
Halifax, Nova Scotia, CanadaCanadian Center for Vaccinology, IWK Health Centre
Jan 19, 2022
Covid19, Vaccine Refusal Trial in Boston (Messaging informed by construal level theory, Usual Care)
Active, not recruiting
- Covid19
- Vaccine Refusal
- Messaging informed by construal level theory
- Usual Care
-
Boston, MassachusettsMass General Brigham
Jun 2, 2022
Typhoid Fever Trial in Kisantu (Vi-TT)
Not yet recruiting
- Typhoid Fever
- Vi-TT
-
Kisantu, Congo, The Democratic Republic of theHôpital Saint Luc de Kisantu
Nov 12, 2021
Cholera Vaccination in Endemic Areas - Clinical Surveillance
Recruiting
- Cholera
-
Goma, Congo, The Democratic Republic of theAnais Broban
May 12, 2021
Influenza Trial in Baltimore (H5N1 pISV)
Completed
- Influenza
- H5N1 pISV
-
Baltimore, MarylandCenter for Immunization Research, Johns Hopkins Bloomberg School
Feb 15, 2022
Cholera Vaccination in Endemic Areas - Seroprevalence
Recruiting
- Cholera
-
Bukama, Haut-Lomami, Congo, The Democratic Republic of the
- +1 more
Apr 13, 2023
Surface Roughness of NITI Archwires
Recruiting
- Autoclave Cycles (Universal and Rapid Cycles)
- sterilization
-
Cairo, EgyptAmira Aboalnaga
May 6, 2023
Ebola Virus Disease, Marburg Virus Disease Trial in Oklahoma City (cAd3-Marburg, cAd3-EBO-S)
Completed
- Ebola Virus Disease
- Marburg Virus Disease
- cAd3-Marburg
- cAd3-EBO-S
-
Oklahoma City, OklahomaOklahoma Blood Institute (OBI)
Aug 2, 2022
Plasmodium Falciparum Malaria Trial in Bandarban, Lama (DHA/piperaquine and a SLD-PQ, Study vaccine R21/Matrix-M™)
Not yet recruiting
- Plasmodium Falciparum Malaria
- DHA/piperaquine and a SLD-PQ
- Study vaccine R21/Matrix-M™
-
Bāndarban, Bangladesh
- +1 more
Sep 28, 2023
Does Repeat Influenza Vaccination Constrain Influenza Immune
Recruiting
- Influenza, Human
- SARS-CoV-2 Infection
- Influenza vaccination: Fluarix Tetra, Vaxigrip Tetra, Fluquadri, Fluad Quad, Afluia Quad, Flucelvax Quad
- SARS-CoV-2 vaccination: Comirnaty or Vaxzevria
-
New Lambton Heights, New South Wales, Australia
- +5 more
Nov 7, 2022
Tuberculosis Trial in Worcester (MTBVAC, BCG)
Completed
- Tuberculosis
- MTBVAC
- BCG
-
Worcester, Western Cape, South AfricaSATVI: Worcester
Aug 26, 2022
HBV Immunity and HBV Vaccination in NAFLD in Canada
Completed
- Non-Alcoholic Fatty Liver Disease
- +2 more
- Engerix-B
-
Calgary, Alberta, CanadaUniversity of Calgary
Nov 2, 2021
Influenza Vaccine, Cost-Effectiveness, Vaccination Trial in Rajshahi (Quadrivalent Influenza Vaccine)
Recruiting
- Influenza Vaccine
- +2 more
- Quadrivalent Influenza Vaccine
-
Rajshahi, BangladeshRajshahi Medical College Hospital
Aug 13, 2023
Relapsed Neuroblastoma, Refractory Neuroblastoma Trial (Natural Killer Cells, Temozolomide, Irinotecan)
Recruiting
- Relapsed Neuroblastoma
- Refractory Neuroblastoma
- Natural Killer Cells
- +4 more
-
Columbus, OhioNationwide Children's Hospital
Oct 26, 2022
Influenza Prevention Trial in Lenexa, Metairie, Cincinnati (INFLUENZA G1 mHA, Placebo, Al(OH)3)
Recruiting
- Influenza Prevention
- INFLUENZA G1 mHA
- +2 more
-
Lenexa, Kansas
- +2 more
Jun 5, 2023
Influenza Trial in Kraków (M-001, Saline)
Completed
- Influenza
- M-001
- Saline
-
Kraków, Ul. Bobrzyńskiego 14,, Poland
- +1 more
Sep 13, 2021
Sirolimus on Immunizations During Treatment of Kaposiform
Recruiting
- Kaposiform Hemangioendothelioma
-
Shanghai, Shanghai, ChinaChildren's Hospital of Fudan University
Apr 22, 2022
Class II Dental Caries Trial in Cairo (Scotchbond universal adhesive plus, Single bond Universal)
Not yet recruiting
- Class II Dental Caries
- Scotchbond universal adhesive plus
- Single bond Universal
-
Cairo, El Manial, EgyptFaculty of Dentistry, Cairo University
Jun 14, 2023
Hepatitis A Trial (Havrix®)
Withdrawn
- Hepatitis A
- Havrix®
- (no location specified)
Mar 1, 2018
Non-carious Cervical Lesions Trial in Santiago (Evaporation time for 5 seconds, Evaporation time for 25 seconds,
Completed
- Non-carious Cervical Lesions
- Evaporation time for 5 seconds
- +3 more
-
Santiago, Región Metropolitana, ChileMario Felipe Gutiérrez Reyes
Jul 11, 2023
COVID-19 Vaccines in Immunocompromised and Healthy Individuals
Recruiting
- Covid19
- Immunosuppression
- Blood sample
- Saliva sample
-
Graz, AustriaMedical University of Graz
May 9, 2022
Among Vaccinated and Unvaccinated Coronavirus Disease Critical
Not yet recruiting
- Coronavirus Infections
- Critical Illness
- (no location specified)
Apr 9, 2022